E37: Errik Anderson on Co-Founding 20 Biotech Startups Cumulatively Worth $10B+
How I Invest with David Weisburd
00:00
The Economics and Costs of Starting a Biotech Company
This chapter explores the costs associated with starting a biotech company, comparing it to the early days of tech investing. It discusses the shift in power from investors to founders in 2021 and efforts to drive down the cost of initial biotech experiments. The chapter also delves into the challenges of achieving high returns on large funds in venture capital and the benefits of collaboration in the industry.
Transcript
Play full episode
